Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic neuroscience Portfolio — U.S. Revenue ($M) ($M)
Medtronic Form 8-K U.S. Revenue Tables
Latest, FY2026
6,875
Period ended Apr 30, 2026
Change on a year earlier
+2.4%
6,713 in FY2025
History
7 years
Since FY2020
Sources
6
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Neuroscience Portfolio — U.S. Revenue ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2026 | Apr 30, 2026 | 6,875 | +2.4% | Medtronic SEC 8K_EARNINGS — FY2026Q4 (filed 2026-06-03) ↗ |
| FY2025 | Apr 30, 2025 | 6,713 | +6.5% | Medtronic SEC 8K_EARNINGS — FY2026Q4 (filed 2026-06-03) ↗ |
| FY2024 | Apr 30, 2024 | 6,305 | +4.8% | Medtronic SEC 8K_EARNINGS — FY2025Q4 (filed 2025-05-21) ↗ |
| FY2023 | Apr 30, 2023 | 6,018 | +4.6% | Medtronic SEC 8K_EARNINGS — FY2024Q4 (filed 2024-05-23) ↗ |
| FY2022 | Apr 30, 2022 | 5,753 | +5.4% | Medtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗ |
| FY2021 | Apr 30, 2021 | 5,456 | +6.5% | Medtronic SEC 8K_EARNINGS — FY2022Q4 (filed 2022-05-26) ↗ |
| FY2020 | Apr 30, 2020 | 5,122 | – | Medtronic SEC 8K_EARNINGS — FY2021Q4 (filed 2021-05-27) ↗ |
Breakdown
What makes up neuroscience portfolio — u.s. revenue ($m)
Cite this data
StockData. (2026). Medtronic Neuroscience Portfolio — U.S. Revenue ($M) ($M), annual FY2020–FY2026 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/neuro-port-us-rev
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.